biote Corp. (BTMD) vs Envoy Medical, Inc. (COCH)
A side-by-side comparison of biote Corp. and Envoy Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.14HealthcareDelayed quote: Oct 6, 2026, 10:06 AM EDT
COCH
Envoy Medical, Inc.
$0.66HealthcareDelayed quote: Oct 6, 2026, 9:59 AM EDT
Total return — BTMD vs COCH
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)COCH -93.3% (-41.8%/yr)BTMD compounded faster over this window
BTMD COCH
BTMD vs COCH: by the numbers
- •COCH is the larger company ($51M vs $50M market cap).
- •BTMD is profitable (3.19% net margin) while COCH runs a net loss (-11304.83%).
Metrics side by side
Valuation
| Metric | BTMD | COCH |
|---|---|---|
| P/E ratio | 9.77 | N/A |
| P/S ratio | 0.27 | 246.13 |
| P/B ratio | N/A | 15.42 |
| EV / EBITDA | 9.02 | N/A |
| FCF yield | 39.14% | N/A |
Profitability
| Metric | BTMD | COCH |
|---|---|---|
| Gross margin | 71.46% | -262.66% |
| Operating margin | 18.50% | -9240.66% |
| Net margin | 3.19% | -11304.83% |
| ROE | N/A | -708.48% |
| ROIC | 13.63% | -208.76% |
Growth (annualized)
| Metric | BTMD | COCH |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | N/A |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -41.73% |
Frequently asked
- Is BTMD or COCH more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus COCH at -11304.83%.
- How have BTMD and COCH total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and COCH delivered -41.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROEEnvoy Medical ROEbiote operating marginEnvoy Medical operating marginbiote revenue growthEnvoy Medical revenue growthbiote free cash flowEnvoy Medical free cash flow
biote & Envoy Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.